The Trinity College Dublin spinout is targeting a form of prostate gland enlargement with a device that could be installed in under 15 minutes.

Proverum Medical, an Ireland-based prostatic urethra therapy spinout from Trinity College Dublin, has closed a $4.2m seed round led by the spinout-focused University Bridge Fund, according to MedicalDesign & Outsourcing.

Angel syndicates Hban Medtech, Irrus Investments and Boole Investment all took part in the round, as did Xenium Capital.

Proverum Medical has developed a surgical implant to treat a prostate gland enlargement known as symptomatic benign prostatic hyperplasia, which mainly affects men over the age of 80 and can lead…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?